Opinion: What’s going on in Joe Biden’s brain?
At the Democratic National Convention in Chicago on Monday night, President Biden took the stage…
Category: Medicine
STAT+: Congressional probe questions clinical trials run in China, citing Army involvement
A House committee is investigating whether brand drug companies are collaborating with the Chinese military…
Does Ozempic increase the risk of suicidal thoughts? A new study muddles the picture
A new observational study found that people taking Ozempic and Wegovy appeared to experience suicidal…
Carbon Health founder steps back from top role, Kaiser hospitals roll out AI scribe
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
Abortion rights and drug pricing program take spotlight at first night of DNC
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Lilly’s Zepbound slashed risk of developing diabetes
Eli Lilly’s obesity drug Zepbound significantly cut the risk of developing type 2 diabetes, showing…
STAT+: Q&A: How the FDA could use AI for drug and device safety surveillance
The Food and Drug Administration’s responsibilities don’t end when a drug hits the market after…
Teamwork is good for science — but maybe not for young researchers’ careers
Science is a team sport, and those teams are getting larger. While that expansion might…
Opinion: Mask bans disenfranchise millions of Americans with disabilities
Last week, a mask ban in Nassau County, New York was signed into law. If…
STAT+: What to know about Alnylam’s upcoming readout on its heart drug
Next week, the biopharma world will see eagerly awaited results from a trial that could…
Opinion: Improving the FDA-EMA parallel scientific advice program to advance complex generics
Off-patent medicines provide people with access to high-quality essential treatment options that can be significantly…
STAT+: Another suit filed against FDA over lab-developed test rule
A group representing molecular pathologists sued the Food and Drug Administration on Monday over its…
STAT+: Democratic platform favors slate of smaller goals over a health overhaul
WASHINGTON — Gone are the days when Democrats bickered over wholesale reform of the American…
.jpg)
Patient volumes have stormed back into hospitals
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
Opinion: Graphic mpox images to educate the public are deeply problematic
For the second time in three years, the WHO has declared an mpox outbreak a…
STAT+: Pharmalittle: We’re reading about FTC scrutiny of a Novo deal, a Genentech reorganization, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: AI drug firm Recursion moves from survival to industry domination
SALT LAKE CITY — On paper, Recursion Pharmaceuticals shouldn’t have worked. The company — or, at…
Study exposes the dangerous ‘hidden’ mental burden of cancer on patients’ spouses
The distress from receiving a cancer diagnosis is something that clinicians widely anticipate in patients,…
STAT+: Peter Orszag wants the FTC and DOJ to stop challenging health care mergers
Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust…
STAT+: Will the FTC challenge a deal that would give Novo Nordisk control of some Catalent plants?
As the Federal Trade Commission scrutinizes the pharmaceutical industry, there is growing debate about whether…
Opinion: Private equity: health care’s vampire
Private equity firms are sucking the resources out of America’s hospitals and nursing homes, and…
5 health issues to watch for at the Democratic National Convention
WASHINGTON — Democrats have set the stage for a convention this week packed with boasts…
STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy
It’s been a hard week for the psychedelics pioneer Rick Doblin. First, the Food and…
Opinion: First Opinion readers on Noah Lyles and Covid-19, the dearth of geriatricians, PBMs, and more
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences…
Opinion: STAT+: What the newly released Medicare prices for 10 drugs do and don’t tell us
For many of us, Thursday was Health-Policy-Wonk Festivus. The Centers for Medicare & Medicaid Services…
Harris pledges to scrap billions in medical debt with new presidential platform
WASHINGTON — Vice President Harris says she wants to cancel billions of dollars in medical…
More than 70 babies have been born from uterus transplants: ‘It’s a complete new world’
The first modern attempt at transferring a uterus from one human to another occurred at…
‘Zoobiquity’: How animals have figured out disease better than humans
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
STAT+: Pharmalittle: We’re reading about a Covid-flu shot setback, mpox vaccine supplies, and more
And so, another working week will soon draw to a close. Not a moment too…
Is pharma still fearful of the Inflation Reduction Act?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pfizer and BioNTech effort to develop Covid-influenza combination vaccine sees setback
Pfizer and BioNTech said Friday that their combined mRNA vaccine candidate against influenza and Covid-19…
As climate changes, scorching summers bring deadly heat for people with disabilities
Degree by degree, the earth’s temperature ticks up. Heat records fall as reliably as the…
To counter mpox, vaccine maker could ramp up by another 8 million doses next year
When mpox first began to spread internationally in 2022, affected countries scrambled to buy some…
Opinion: Gilead must be held accountable for the harm caused by ‘patent hopping’ an HIV treatment
Gilead Sciences, a pharma company that dominates the market for HIV treatments, agreed in June…
Clinical trials exclude disabled Americans because federal agencies failed them, new report finds
People with disabilities are largely excluded from clinical trials that could benefit them because federal…
STAT+: UnitedHealthcare’s latest contract dispute, this time with Trinity Health, leaves thousands out-of-network
A widespread, monthslong contract dispute between UnitedHealthcare and Trinity Health has created a confusing patchwork…
STAT+: What do Biden’s drug price comparisons reveal? Not much
WASHINGTON — The White House is touting just how much its new Medicare negotiation process…
STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy
Lykos Therapeutics, whose MDMA-assisted psychotherapy for post-traumatic stress disorder was rejected late last week by…
Listen: Drug pricing drops & psychedelics under fire
Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and…
Antiviral used for mpox no better than placebo, NIH says
The National Institutes of Health said Thursday that an antiviral often used to treat mpox…
New Medicare drug prices, antimicrobial-resistant meningitis, unlucky American women
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
STAT+: Boston’s lab market is in as rough shape
When demand for office space cratered during the Covid-19 pandemic, many developers in the Boston…
.jpg)
STAT+: The business of CRISPR’d medicine: Not great
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
We have mpox vaccines now. But how will they be distributed?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about Medicare drug savings, Lilly warning doctors, and more
Top of the morning to you, and a fine one it is. The skies are…
Medicare drug price negotiation didn’t benefit Biden — but it may help Harris
WASHINGTON — When Vice President Kamala Harris takes the stage at the Democratic National Convention…
STAT+: Medicare announces drug prices for historic first round of negotiations
WASHINGTON — The day drug makers dreaded has finally arrived. Medicare officials on Thursday unveiled…
Opinion: HHS says it is working against climate change. But it’s really climate washing
The U.S. Department of Health and Human Services has stated it will do all that…
Opinion: Can AI help ease medicine’s empathy problem?
Modern medicine has an empathy problem. Artificial intelligence — done right — might be able…